Your browser doesn't support javascript.
loading
Orthologous CRISPR-Cas9 enzymes for combinatorial genetic screens.
Najm, Fadi J; Strand, Christine; Donovan, Katherine F; Hegde, Mudra; Sanson, Kendall R; Vaimberg, Emma W; Sullender, Meagan E; Hartenian, Ella; Kalani, Zohra; Fusi, Nicolo; Listgarten, Jennifer; Younger, Scott T; Bernstein, Bradley E; Root, David E; Doench, John G.
Afiliação
  • Najm FJ; Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
  • Strand C; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Donovan KF; Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Hegde M; Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
  • Sanson KR; Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
  • Vaimberg EW; Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
  • Sullender ME; Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
  • Hartenian E; Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
  • Kalani Z; Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
  • Fusi N; Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
  • Listgarten J; Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
  • Younger ST; Microsoft Research New England, Cambridge, Massachusetts, USA.
  • Bernstein BE; Microsoft Research New England, Cambridge, Massachusetts, USA.
  • Root DE; Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
  • Doench JG; Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
Nat Biotechnol ; 36(2): 179-189, 2018 02.
Article em En | MEDLINE | ID: mdl-29251726
ABSTRACT
Combinatorial genetic screening using CRISPR-Cas9 is a useful approach to uncover redundant genes and to explore complex gene networks. However, current methods suffer from interference between the single-guide RNAs (sgRNAs) and from limited gene targeting activity. To increase the efficiency of combinatorial screening, we employ orthogonal Cas9 enzymes from Staphylococcus aureus and Streptococcus pyogenes. We used machine learning to establish S. aureus Cas9 sgRNA design rules and paired S. aureus Cas9 with S. pyogenes Cas9 to achieve dual targeting in a high fraction of cells. We also developed a lentiviral vector and cloning strategy to generate high-complexity pooled dual-knockout libraries to identify synthetic lethal and buffering gene pairs across multiple cell types, including MAPK pathway genes and apoptotic genes. Our orthologous approach also enabled a screen combining gene knockouts with transcriptional activation, which revealed genetic interactions with TP53. The "Big Papi" (paired aureus and pyogenes for interactions) approach described here will be widely applicable for the study of combinatorial phenotypes.
Assuntos

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Prevencao_e_fatores_de_risco / Hereditariedade Base de dados: MEDLINE Assunto principal: Testes Genéticos / RNA Guia de Cinetoplastídeos / Epistasia Genética / Sistemas CRISPR-Cas Limite: Humans Idioma: En Revista: Nat Biotechnol Assunto da revista: BIOTECNOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Prevencao_e_fatores_de_risco / Hereditariedade Base de dados: MEDLINE Assunto principal: Testes Genéticos / RNA Guia de Cinetoplastídeos / Epistasia Genética / Sistemas CRISPR-Cas Limite: Humans Idioma: En Revista: Nat Biotechnol Assunto da revista: BIOTECNOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos